Media coverage
2Media coverage
Title Janssen's Invokana Now Approved to Reduce Risk of Major CV Events Media name/outlet Research & Development Country United States Date 10/31/18 Persons Ralph A Defronzo Title Janssen's Invokana Now Approved to Reduce Risk of Major CV Events Media name/outlet PharmaceuticalProcessing Country United States Date 10/31/18 Persons Ralph A Defronzo